Alembic Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Profit before tax

704.23

345.93

658.01

1,416.60

1,166.79

Net cashflow-operating activity

772.77

730.25

545.26

1,485.30

539.75

Net cash used in investing activity

-329.02

-460.98

-368.72

-925.55

-822.31

Netcash used in fin. activity

-445.29

-261.16

-216.64

-533.60

166.13

Net inc/dec in cash and equivlnt

-1.54

8.11

-40.10

25.22

-116.02

Cash and equivalnt begin of year

21.67

13.56

53.66

28.22

144.24

Cash and equivalnt end of year

20.13

21.67

13.56

53.44

28.22